488 related articles for article (PubMed ID: 19165648)
41. Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee.
Grace D; Rogers J; Skeith K; Anderson K
J Rheumatol; 1999 Dec; 26(12):2659-63. PubMed ID: 10606379
[TBL] [Abstract][Full Text] [Related]
42. Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoarthritis receiving concomitant low dose aspirin: pooled analysis of 2 trials.
Goldstein JL; Bello AE; Spalding W; Suh S; Fort JG
J Rheumatol; 2005 Jan; 32(1):111-7. PubMed ID: 15630735
[TBL] [Abstract][Full Text] [Related]
43. Clinical trial: the impact of cyclooxygenase inhibitors on gastrointestinal recovery after major surgery - a randomized double blind controlled trial of celecoxib or diclofenac vs. placebo.
Wattchow DA; De Fontgalland D; Bampton PA; Leach PL; McLaughlin K; Costa M
Aliment Pharmacol Ther; 2009 Nov; 30(10):987-98. PubMed ID: 19694636
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial.
Roth SH; Shainhouse JZ
Arch Intern Med; 2004 Oct; 164(18):2017-23. PubMed ID: 15477437
[TBL] [Abstract][Full Text] [Related]
45. Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis.
Petri M; Hufman SL; Waser G; Cui H; Snabes MC; Verburg KM
J Rheumatol; 2004 Aug; 31(8):1614-20. PubMed ID: 15290743
[TBL] [Abstract][Full Text] [Related]
46. A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model.
Brereton N; Pennington B; Ekelund M; Akehurst R
J Med Econ; 2014 Sep; 17(9):677-84. PubMed ID: 24914585
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials.
Biegert C; Wagner I; Lüdtke R; Kötter I; Lohmüller C; Günaydin I; Taxis K; Heide L
J Rheumatol; 2004 Nov; 31(11):2121-30. PubMed ID: 15517622
[TBL] [Abstract][Full Text] [Related]
48. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
[TBL] [Abstract][Full Text] [Related]
49. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib.
Tannenbaum H; Berenbaum F; Reginster JY; Zacher J; Robinson J; Poor G; Bliddal H; Uebelhart D; Adami S; Navarro F; Lee A; Moore A; Gimona A
Ann Rheum Dis; 2004 Nov; 63(11):1419-26. PubMed ID: 15020310
[TBL] [Abstract][Full Text] [Related]
50. Analgesic efficacy of perioperative celecoxib in ambulatory arthroscopic knee surgery: a double-blind, placebo-controlled study.
Ekman EF; Wahba M; Ancona F
Arthroscopy; 2006 Jun; 22(6):635-42. PubMed ID: 16762702
[TBL] [Abstract][Full Text] [Related]
51. Effects of celecoxib on blood loss, pain, and recovery of function after total knee replacement: a randomized placebo-controlled trial.
Meunier A; Lisander B; Good L
Acta Orthop; 2007 Oct; 78(5):661-7. PubMed ID: 17966026
[TBL] [Abstract][Full Text] [Related]
52. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
[TBL] [Abstract][Full Text] [Related]
53. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group.
Cannon GW; Caldwell JR; Holt P; McLean B; Seidenberg B; Bolognese J; Ehrich E; Mukhopadhyay S; Daniels B
Arthritis Rheum; 2000 May; 43(5):978-87. PubMed ID: 10817549
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.
Pareek A; Chandanwale AS; Oak J; Jain UK; Kapoor S
Curr Med Res Opin; 2006 May; 22(5):977-88. PubMed ID: 16709320
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Schnitzer TJ; Beier J; Geusens P; Hasler P; Patel SK; Senftleber I; Gitton X; Moore A; Sloan VS; Poór G
Arthritis Rheum; 2004 Aug; 51(4):549-57. PubMed ID: 15334426
[TBL] [Abstract][Full Text] [Related]
57. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients.
Vorsanger G; Xiang J; Jordan D; Farrell J
Clin Ther; 2007; 29 Suppl():2520-35. PubMed ID: 18164919
[TBL] [Abstract][Full Text] [Related]
58. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial.
Altman RD; Dreiser RL; Fisher CL; Chase WF; Dreher DS; Zacher J
J Rheumatol; 2009 Sep; 36(9):1991-9. PubMed ID: 19648310
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state.
Tubach F; Ravaud P; Baron G; Falissard B; Logeart I; Bellamy N; Bombardier C; Felson D; Hochberg M; van der Heijde D; Dougados M
Ann Rheum Dis; 2005 Jan; 64(1):34-7. PubMed ID: 15130902
[TBL] [Abstract][Full Text] [Related]
60. Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis.
Fleischmann R; Tannenbaum H; Patel NP; Notter M; Sallstig P; Reginster JY
BMC Musculoskelet Disord; 2008 Mar; 9():32. PubMed ID: 18328090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
